Advice to GP practices to exercise vigilance and caution when prescribing Amitriptyline, Paroxetine and Ivabradine simultaneously to prevent patient harm.
Latest News
** Scotland Only ** - Repeat Prescription Changes Not Triggering / Included in Emergency Care Summary (ECS) Data Extract from Vision
Tags: Clinical Safety
Clinical safety advisory post relating to changes to a patient's repeat medication information not always triggering an ECS extract of data from Vision.
MHRA advice that a review by two specialists is required for patients initiating valproate under 55 years but not for men who are already taking valproate.
Ongoing Supply Issues with Pancreatic Enzyme Replacement Therapy (PERT) Preparations
Tags: News,Prescribing
Advisory information regarding National Patient Safety Alert (NPSA) issued by DHSC relating to the shortage of Pancreatic enzyme replacement therapy (PERT)
Vision 3 - Javascript Error Thrown in Consultation Manager Mailbox View on Cegedim Cloud Hosted Systems
Tags: Clinical Safety,Vision 3
Clinical safety advice relating to Javascript error displayed on Cegedim Cloud hosted systems instead of clinical content of certain message types.
** Scotland Only ** - Preferred Pharmacy and Registered CMS Pharmacy Both Printing on GP10 Prescription
Tags: Clinical Safety,Vision 3
Clinical safety advisory post relating to addresses of both preferred pharmacy and registered CMS pharmacy details being printed on a new CMS script.
Clinical safety advisory post relating to incorrect volume/presentation of Enoxaparin and some other products prescribed in the form of pre-filled syringes.
Vision 3 - Treat Days: Not Displaying Correct Number When Prescribing Methotrexate To Be Taken As A Once Weekly Dose
Tags: Vision 3
Advisory post relating to incorrectly calculated / displayed number of treatment days for Methotrexate where prescribed to be taken as a once-weekly dose.
Clinical Safety Issue - Incorrect Interaction Severity Level for Certain Drug Pairings (Vision 3)
Tags: Clinical Safety,Vision 3
Clinical safety advisory post relating to some major interactions not displaying in Vision 3 where set up to display of severity 'severe and major only'.
Clinical Safety Issue: SCI Pathology Abnormal Results Not Highlighted in Red Text in Vision 3 Consultation Manager Mailbox View on NSS Hosted Systems
Tags: Clinical Safety,Vision 3
Clinical safety advice relating to SCI pathology abnormal results not highlighted in Red in Vision Consultation Manager Mailbox view on NSS hosted systems.